Literature DB >> 15667912

An audit of the investigation and initial management of adults presenting with possible bacterial meningitis.

Mairi M Cullen1.   

Abstract

OBJECTIVES: This study was carried out to determine local levels of compliance with guidelines from the British Infection Society (BIS) for the early management and investigation of adult patients presenting with possible bacterial meningitis [J Infect 39 (1999) 1; J Infect 46 (2003) 75].
METHODS: Patients investigated for possible bacterial meningitis at Wythenshawe Hospital, Manchester were identified retrospectively by a computer search of microbiology requests. The clinical presentation, laboratory investigations and early antibiotic management were reviewed.
RESULTS: Only two of 26 patients who presented over a 9-month period were confirmed to have bacterial meningitis. Basic laboratory investigations were carried out on all patients. Samples for more specific investigations to determine the aetiological agent such as polymerase chain reaction, serology or throat swab culture, were frequently omitted by the clinicians. The choice of antibiotic therapy was generally appropriate for the treatment of bacterial meningitis with large variation in the dosage prescribed. Both patients with confirmed bacterial meningitis received appropriate doses.
CONCLUSIONS: Compliance with BIS guidelines was incomplete in a group of patients presenting with possible bacterial meningitis. Access to a simplified outline of recommendations for early investigation and management of adult patients with possible bacterial meningitis may optimise guideline compliance and patient outcome.
SUMMARY: Appropriate early investigation and management of bacterial meningitis in adults can optimise the outcome of this high mortality disease. Guidelines published by the BIS in 1999 detailed the recommended initial management of such patients [J Infect 39 (1999) 1]. In this study, the level of adherence to these guidelines was investigated for patients with possible bacterial meningitis who presented to a hospital in Manchester. The results showed that basic investigations such as peripheral blood count and blood cultures were almost invariably carried out, whereas, more specific investigations such as meningococcal PCR, serology and throat swab were frequently omitted. The choice of antibiotic was in agreement with the guidelines for the majority of cases but highlighted a considerable variability in dosage prescribed. The availability of a simple flow-chart outlining the early management of suspected bacterial meningitis and meningococcal septicaemia in adults produced by the BIS in 2003 may raise awareness of and compliance with their guidelines, thus optimising patient outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15667912     DOI: 10.1016/j.jinf.2003.11.016

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Investigation of the Selection and Timing of Pharmacological Therapy in Community-Acquired Bacterial Meningitis.

Authors:  Jared Sheley; Dave Willman; Julie Downen; Scott Bergman
Journal:  P T       Date:  2016-07

2.  Adult community-acquired bacterial meningitis requiring ICU admission: epidemiological data, prognosis factors and adherence to IDSA guidelines.

Authors:  H Georges; A Chiche; S Alfandari; P Devos; N Boussekey; O Leroy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11       Impact factor: 3.267

3.  In-hospital management of children with bacterial meningitis in Italy.

Authors:  Marta Ciofi degli Atti; Susanna Esposito; Luciana Parola; Lucilla Ravà; Gianluigi Gargantini; Riccardo Longhi
Journal:  Ital J Pediatr       Date:  2014-11-14       Impact factor: 2.638

4.  Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR).

Authors:  Jayne Ellis; David Harvey; Sylviane Defres; Arjun Chandna; Eloisa MacLachlan; Tom Solomon; Robert S Heyderman; Fiona McGill
Journal:  BMJ Open       Date:  2022-07-13       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.